ARegPKD is a prospective and retrospective, international, multicenter observational study of patients suffering from ARPKD. With the support of multiple scientific societies and patient support groups ARegPKD follows the clinical course of ARPKD patients through pseudonymous web-based data entry with yearly follow-ups and a special focus on European countries. Associated biobanking aims to facilitate translational research approaches.
Inclusion criteria:
- Clinical diagnosis of ARPKD at any age
- Informed consent
Exclusion criteria:
- Diagnosis of any other cystic kidney disease
Contact information:
Max C. Liebau, MD
+ 49-(0)221-478-4319
max.liebau@uk-koeln.de
